Atossa Therapeutics Inc (ATOS)
1.79
-0.04
(-2.19%)
USD |
NASDAQ |
Mar 28, 16:00
1.82
+0.03
(+1.68%)
After-Hours: 20:00
Atossa Therapeutics Enterprise Value: 130.26M for March 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 28, 2024 | 130.26M |
March 27, 2024 | 135.28M |
March 26, 2024 | 131.52M |
March 25, 2024 | 142.79M |
March 22, 2024 | 115.23M |
March 21, 2024 | 116.48M |
March 20, 2024 | 110.21M |
March 19, 2024 | 100.19M |
March 18, 2024 | 67.61M |
March 15, 2024 | 67.61M |
March 14, 2024 | 56.33M |
March 13, 2024 | 63.85M |
March 12, 2024 | 70.12M |
March 11, 2024 | 56.33M |
March 08, 2024 | 42.55M |
March 07, 2024 | 43.80M |
March 06, 2024 | 50.07M |
March 05, 2024 | 33.78M |
March 04, 2024 | 33.78M |
March 01, 2024 | 31.27M |
February 29, 2024 | 28.39M |
February 28, 2024 | 31.27M |
February 27, 2024 | 35.03M |
February 26, 2024 | 28.78M |
February 23, 2024 | 28.77M |
Date | Value |
---|---|
February 22, 2024 | 33.78M |
February 21, 2024 | 32.53M |
February 20, 2024 | 33.78M |
February 16, 2024 | 32.53M |
February 15, 2024 | 32.53M |
February 14, 2024 | 35.03M |
February 13, 2024 | 27.51M |
February 12, 2024 | 30.02M |
February 09, 2024 | 23.22M |
February 08, 2024 | 23.75M |
February 07, 2024 | 24.67M |
February 06, 2024 | 18.12M |
February 05, 2024 | 10.60M |
February 02, 2024 | 12.85M |
February 01, 2024 | 11.17M |
January 31, 2024 | 12.98M |
January 30, 2024 | 12.73M |
January 29, 2024 | 14.73M |
January 26, 2024 | 8.718M |
January 25, 2024 | 6.212M |
January 24, 2024 | 7.34M |
January 23, 2024 | 9.119M |
January 22, 2024 | 8.342M |
January 19, 2024 | 8.718M |
January 18, 2024 | 8.217M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-53.80M
Minimum
Dec 28 2022
903.93M
Maximum
Jun 25 2021
53.27M
Average
7.622M
Median
Apr 12 2019
Enterprise Value Benchmarks
Perspective Therapeutics Inc | 317.63M |
Electromed Inc | 128.54M |
Xtant Medical Holdings Inc | 164.75M |
Asensus Surgical Inc | 41.49M |
Senseonics Holdings Inc | 213.58M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -6.229M |
Total Expenses (Quarterly) | 7.468M |
EPS Diluted (Quarterly) | -0.05 |
Earnings Yield | -13.41% |
Normalized Earnings Yield | -4358.49 |